Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
LuCAS-Plus
LuCAS-Plus
Monitor Corporation
LuCAS-plus can automatically detect and suggest nodules through its AI algorithm. The main aim of this solution is to carry out an automated and interconnected medical diagnostic process to minimize the error in diagnostic results. Also, it can compare analysis between current and previous CT images in order to help the doctor’s workflow.
Information source:
Vendor
Last updated:
March 23, 2022
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
LuCAS-Plus
Company
Monitor Corporation
Subspeciality
Chest
Modality
CT
Disease targeted
Lung cancer
Key-features
Nodule detection and localization, nodule characterization, nodule quantification, segmentation and measurement, longitudinal follow-up
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps)
Technical Specifications
Data characteristics
Population
Asymptomatic population, all ages
Input
3D, constrast, non-contrast, CT, low-dose CT
Input format
DICOM
Output
Nodule coordinate, nodule segmentation, nodule size, nodule type, nodule location, nodule change
Output format
DICOM
Technology
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment
Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
1 - 10 minutes
Regulatory
Certification
CE
Certified, Class IIa
, MDD
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
LuCAS-Plus is comprised of computer assisted reading tools designed to aid the radiologist in the detection of pulmonary nodules during review of CT examinations of the chest on an asymptomatic population. The LuCAS-Plus requires both lungs be in the field of view. It is used to aid users in making a final diagnosis and patient management decisions by providing adjunctive information. Patient management decisions should not be made solely based on analysis by LuCAS-Plus.
Market
Market presence
On market since
07-2020
Distribution channels
Countries present (clinical, non-research use)
1
Paying clinical customers (institutes)
0
Research/test users (institutes)
2
Pricing
Pricing model
Pay-per-use, Subscription, One-time license fee
Based on
Number of users, Number of installations, Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers